
đ Buy Borrow Die, SPCX vs MSTR, SOL vs SUI. Compute Is the New Oil | IA Q&A
In this IA Q&A, James breaks down capital rotation, the battle for compute dominance, and the reality check for crypto narratives.
1. Buy, Borrow, Die & The Mandate for Rotation- The Concept: Buy assets, borrow against them, die, and pass them on tax-free (Step-up basis).
- The Catch: "Time is your enemy if you pledge weakness." Most companies are not perpetual "Up-Only" compounders. Even Nvidia and Home Depot had long flat periods.
- The Solution: Rotation is mandatory. James warns: "Don't hold a loser just to avoid taxes. Dead capital with leverage explodes a portfolio. Pay the 20% LTCG tax and rotate into better horses."
- MicroStrategy (MSTR): A bet on Bitcoin ($130k-$200k target) and a sustained NAV premium (1x-1.5x). Headwind: ATM dilution is a killer. Target upside is ~66%.
- SpaceX (SPCX): Higher asymmetric upside (3.6x by 2028). Thesis relies on massive compute expansion (>10GW by 2027) and building data centers in orbit.
- The Merger: A Tesla/SPCX merger is highly likely (65% by end of 2027). The Roadster event is a brilliant marketing bridge.
- Verdict: James leans heavily toward SpaceX for returns, acknowledging the massive execution risk.
- Solana (SOL): The undisputed adoption leader. 76% of AI agent transactions. 146 million daily transactions, 5.2 million daily users, $6 billion TVL.
- Sui (SUI): Interesting tech thesis (object-centric, quantum-safe), but adoption is failing. TVL crashed from $3B to $500M. Phantom wallet dropped support. Move language limits developers.
- The Lesson: "AI agents don't care about quantum safety. They want finality, liquidity, and reliability." Solana delivers; SUI promises.
- Shift: OpenAI & Anthropic are pouring compute into internal projects (wet lab in SF, versions 6/7). They are targeting medical breakthroughs (cancer, longevity).
- Business Model: They won't become pharma companies. They will identify the breakthrough and license it to Big Pharma (Pfizer, Novo Nordisk). This avoids FDA headaches and captures massive upfront value.
- Bitcoin (Cold Storage): Don't sell! Send it to Fidelity or Schwab. They custody it and offer loans against the BTC â no taxable event.
- Broadcom vs. Marvell: Broadcom target $1,300 (6.3x). Marvell is seen as the stronger compounder (target $1,500, 71% CAGR).
- Charity: Donation to Chaba the elephant. "It makes the whole thing worth it."






